Cite

HARVARD Citation

    Abaza, Y. et al. (2017). Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies. Cancer. 123 (24), pp. 4851-4859. [Online]. 
  
Back to record